Jack A. Schalken

Researcher Next ID · RN-033830

Researcher · Biochemistry, Genetics and Molecular Biology

Nijmegen, Netherlands

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Prostate Cancer Treatment and Research

Prostate Cancer Diagnosis and Treatment

Cancer, Lipids, and Metabolism

Cancer Genomics and Diagnostics

Bladder and Urothelial Cancer Treatments

Genomic Predictors of Outcome in Prostate Cancer
European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.04.008
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv257
Prevention and early detection of prostate cancer
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Nature Genetics · 2011 · https://doi.org/10.1038/ng.926
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.08.003
Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
Science Translational Medicine · 2010 · https://doi.org/10.1126/scitranslmed.3001513
Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.03.029
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Nature Genetics · 2009 · https://doi.org/10.1038/ng.296
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2008.06.071
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
PubMed · 1999

No projects listed.